Five recent developments involving laser treatments

Recent actions reported on Healio.com/Aesthetics include the FDA granting additional indications for the use of Syneron Candela’s CO₂ device.

Other actions include study results finding that Q-switched 660-nm Nd:YAG laser significantly reduced the objective melanin average when treating facial lentigines in Asian women compared with the 532-nm laser:

FDA expands indications for Syneron Candela’s CO₂ laser device

The FDA has granted additional indications for the use of Syneron Candela’s CO₂ laser device, according to a press release.

New indications include wrinkles, scars, a wide range of dermatology and plastic surgery indications, and gynecology applications, including vaginal treatments. Read more

Q-switched 660-nm Nd:YAG laser effectively reduced melanin levels in facial lentigines

A Q-switched 660-nm Nd:YAG laser significantly reduced the objective melanin average when treating facial lentigines in Asian women compared with the 532-nm laser, according to study results.

Researchers treated half of each face of eight Korean women with Fitzpatrick skin type 3-4 and facial solar lentigines with either 660-nm or 532-nm Q-switched nd:YAG lasers. Read more

Syneron launches dual wavelength fractional modality for picosecond laser

Syneron Medical announced the international launch of PicoWay Resolve, a dual wavelength fractional modality for the PicoWay picosecond laser.

The launch of the modality, which features 532 nm and 1064 nm wavelengths, was announced at the European Academy of Dermatology and Venereology Congress in Copenhagen, Denmark, according to a press release. Read more

VIDEO: Roy G. Geronemus, MD, PC, discusses picosecond laser technology for tattoo removal

CHICAGO — In this video perspective, Roy G. Geronemus, MD, PC, discusses the use of new picosecond laser technology for tattoo removal at the American Society for Dermatologic Surgery annual meeting.

Roy G. Geroneumus

“The advantage of the picosecond lasers is the ability to remove certain colors that we could not remove before very easily using nanosecond or Q-switched laser technology,” Geronemus, director of the Laser & Skin Surgery Center of New York and clinical professor of dermatology at New York University Medical Center, said. Watch video

VIDEO: Roy G. Geronemus, MD, PC, on using ablative, nonablative lasers for acne scarring

CHICAGO — In this video perspective, Roy G. Geronemus, MD, PC, discusses the use of ablative and nonablative lasers for treating acne scarring at the American Society for Dermatologic Surgery annual meeting.

“We mix and match the particular type of laser treatment depending on the type of scar and the patient’s tolerance for downtime and healing,” Geronemus, director of the Laser & Skin Surgery Center of New York and clinical professor of dermatology at New York University Medical Center, said. Watch video